NCT00588770 2026-03-03
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
National Cancer Institute (NCI)
Phase 3 Active not recruiting
National Cancer Institute (NCI)
GERCOR - Multidisciplinary Oncology Cooperative Group
University of Chicago
HealthCare Global Enterprise Ltd.
European Organisation for Research and Treatment of Cancer - EORTC